These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15505130)

  • 1. Antibiotics for the secondary prevention of ischemic heart disease: a meta-analysis of randomized controlled trials.
    Wells BJ; Mainous AG; Dickerson LM
    Arch Intern Med; 2004 Oct; 164(19):2156-61. PubMed ID: 15505130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease.
    Vainas T; Stassen FR; Schurink GW; Tordoir JH; Welten RJ; van den Akker LH; Kurvers HA; Bruggeman CA; Kitslaar PJ
    Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):403-11. PubMed ID: 15749042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics in the prevention and treatment of coronary heart disease.
    Meier CR
    J Infect Dis; 2000 Jun; 181 Suppl 3():S558-62. PubMed ID: 10839758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial.
    Leowattana W; Bhuripanyo K; Singhaviranon L; Akaniroj S; Mahanonda N; Samranthin M; Pokum S
    J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S669-75. PubMed ID: 12002908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients.
    Wszola M; Kwiatkowski A; Nosek R; Podsiadly E; Meszaros J; Danielewicz R; Lisik W; Ostrowski K; Chmura A; Adadyński L; Paczek L; Durlik M; Tylewska-Wierzbanowska S; Rowiński W
    Transplant Proc; 2006; 38(1):31-4. PubMed ID: 16504656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chlamydia pneumoniae and myocardial infarction (CLINF). Preliminary randomized controlled study with clarithromycin. CLAINF protocol].
    Vergassola R; Mazzoli S; Pazzagli L; Rabatti L; Abbate R; Taddei V; Acciai S
    Minerva Cardioangiol; 2000 Dec; 48(12):411-25. PubMed ID: 11253326
    [No Abstract]   [Full Text] [Related]  

  • 7. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.
    Bartlett JG
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of bacterial resistance to macrolides.
    Halpern MT; Schmier JK; Snyder LM; Asche C; Sarocco PW; Lavin B; Nieman R; Mandell LA
    J Antimicrob Chemother; 2005 May; 55(5):748-57. PubMed ID: 15772147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolide antibiotics in the treatment of asthma. An update.
    Hernando-Sastre V
    Allergol Immunopathol (Madr); 2010; 38(2):92-8. PubMed ID: 20171003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.
    Dahabreh IJ; Economopoulos K
    Clin Trials; 2008; 5(2):116-20. PubMed ID: 18375649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effectiveness of estrogen replacement therapy to reduce ischemic heart disease--revaluation].
    Ben-Chetrit A; Zacut D; Shimonovitz S
    Harefuah; 2003 Jan; 142(1):32-7, 78. PubMed ID: 12647487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials.
    Saha SA; Molnar J; Arora RR
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):192-204. PubMed ID: 17875946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research.
    de Kruif MD; van Gorp EC; Keller TT; Ossewaarde JM; ten Cate H
    Cardiovasc Res; 2005 Feb; 65(2):317-27. PubMed ID: 15639470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High sensitivity C-reactive protein and immunoglobulin G against Chlamydia pneumoniae and chlamydial heat shock protein-60 in ischemic heart disease.
    Jafarzadeh A; Esmaeeli-Nadimi A; Shariati M
    Iran J Immunol; 2008 Mar; 5(1):51-6. PubMed ID: 18319525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clarithromycin use and risk of death in patients with ischemic heart disease.
    Andersen SS; Hansen ML; Norgaard ML; Folke F; Fosbøl EL; Abildstrøm SZ; Raunsø J; Madsen M; Køber L; Gislason GH; Torp-Pedersen C
    Cardiology; 2010; 116(2):89-97. PubMed ID: 20523043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
    Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
    Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: ertapenem for complicated intra-abdominal infections.
    Falagas ME; Peppas G; Makris GC; Karageorgopoulos DE; Matthaiou DK
    Aliment Pharmacol Ther; 2008 May; 27(10):919-31. PubMed ID: 18266994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atherosclerosis and Chlamydia pneumoniae].
    Larsen MM; Mørn B; Andersen PL; Østergaard LJ
    Ugeskr Laeger; 2002 Dec; 164(50):5920-4. PubMed ID: 12553110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.
    Aviña-Zubieta JA; Choi HK; Sadatsafavi M; Etminan M; Esdaile JM; Lacaille D
    Arthritis Rheum; 2008 Dec; 59(12):1690-7. PubMed ID: 19035419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.